MNDs are neurological disorders that destroy motor neurons, the cells that control skeletal muscle activity such as walking, breathing, speaking, and swallowing.
Ozanimodâ–¼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...
Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of ALS ...
Inhaling xenon gas reduced neuroinflammation and brain atrophy while increasing protective neuronal states in mouse models of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback